Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profusa, Inc. - Common Stock (NQ:PFSA)

1.220 -0.490 (-28.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,973,271
Open 1.280
Bid (Size) 1.150 (200)
Ask (Size) 1.190 (100)
Prev. Close 1.710
Today's Range 0.9404 - 1.380
52wk Range 0.0801 - 30.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Monday's after hours session ↗
Via Chartmill
Which stocks are moving on Monday? ↗
Via Chartmill

Performance

YTD
-83.7%
-83.7%
1 Month
+965.5%
+965.5%
3 Month
+137.8%
+137.8%
6 Month
-83.3%
-83.3%
1 Year
-95.0%
-95.0%

More News

Read More
Monday's session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
From Profusa, Inc.
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Which stocks are gapping on Wednesday? ↗
Via Chartmill
Top movers in Wednesday's pre-market session ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
News headline image
Profusa Announces 1-for-25 Reverse Stock Split
From Profusa, Inc.
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Via Chartmill
Which stocks are most active on Wednesday? ↗
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday. ↗
Via Chartmill
News headline image
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
From Profusa, Inc.
Via GlobeNewswire
Top movers in Thursday's session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
News headline image
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Listing Transfer to The Nasdaq Capital Market
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Receives Favorable Nasdaq Listing Determination
From Profusa, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Profusa, Inc. - Common Stock publicly traded?
Yes, Profusa, Inc. - Common Stock is publicly traded.
What exchange does Profusa, Inc. - Common Stock trade on?
Profusa, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Profusa, Inc. - Common Stock?
The ticker symbol for Profusa, Inc. - Common Stock is PFSA on the Nasdaq Stock Market
What is the current price of Profusa, Inc. - Common Stock?
The current price of Profusa, Inc. - Common Stock is 1.220
When was Profusa, Inc. - Common Stock last traded?
The last trade of Profusa, Inc. - Common Stock was at 07/27/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.